Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Uppsala University
Sponsor

Uppsala University

Sweden Box 256, 751 05 Uppsala, Sweden

About the sponsor

Uppsala University, through the Department of Immunology, Genetics and Pathology, is involved in clinical research on colorectal cancer and neuroendocrine neoplasms, with attention to disease control, tumour recurrence, and treatment response in advanced and metastatic settings.

  • Colorectal cancer
  • Neuroendocrine neoplasms (NENs)
  • Metastatic disease
  • Recurrence-free survival

The oncology portfolio includes research on surgical and locoregional management as well as biologically targeted approaches for advanced tumour disease.

About Specializations

Uppsala University runs clinical trials in conditions such as Colorectal cancer metastatic, Aortic aneurysm, Overweight, Metabolic syndrome, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Colorectal cancer metastatic

Recruiting

Study of Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Fluorouracil in Patients with Colorectal Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Uppsala University

Aortic aneurysm

Recruiting

Study on Metformin Embonate to Slow Growth of Small Abdominal Aortic Aneurysms in Patients Without Diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Uppsala University

Overweight+1

Not yet recruiting

Effect of bupropion hydrochloride and mushroom supplement on body weight in overweight adults: a 52‑week randomized trial

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bupropion Hydrochloride
  • Sponsor:Uppsala University

Atrophic vulvovaginitis

Not recruiting

Study on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen Citrate
  • Sponsor:Uppsala University

Type 2 diabetes mellitus

Not recruiting

Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Uppsala University

Neuroendocrine carcinoma metastatic

Not recruiting

Study of AdVince (Modified Adenovirus) Treatment Through Hepatic Artery Injection in Patients with Advanced Neuroendocrine Neoplasms

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Human Adenovirus C Serotype 5 With E1 Gene Controlled By Chromogranin A Promoter And Hexon Modified With Protein Transduction Domain Motif
  • Sponsor:Uppsala University

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.